Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001415889-24-028058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-11-29 | HALO | Torley Helen | Pres AND CEO, Dir | G - Gift | $0.00 | -10.0K | 666.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | G | D | 10,000 | $0.00 | 666,744 | D | — | — |